Position in ALNY
as of Jun 30, 2026
· filed Jul 22, 2026
Position Value
$5,327,327
-$449,994 QoQ
Shares Held
17,697
+1.4% QoQ
Ownership
0.013%
of shares outstanding
% of Portfolio
0.73%
of 13F equity value
Holder Rank
#237
of 784 holders
Holding Since
Mar 2026
2 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ALNY Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Slow Capital, Inc. holds $36,363,448 across 7 Biotechnology names. ALNY ranks #4 (14.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ONC |
BeOne Medicines Ltd.
|
28,237 | $8,046,697 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
10,613 | $6,617,630 | |
| 3 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
13,274 | $6,593,594 | |
| 4 | ALNY |
Alnylam Pharmaceuticals, Inc.
This page
|
17,697 | $5,327,327 | |
| 5 | CRSP |
CRISPR Therapeutics AG
|
92,894 | $5,066,438 | |
| 6 | BNTX |
BioNTech SE
|
49,696 | $4,624,212 | |
| 7 | IBRX |
ImmunityBio, Inc.
|
10,000 | $87,550 |
All Filings in ALNY
Export CSV
2 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $5,327,327 | 17,697 | Shares | Sole | 2026-07-22 | |
| 2026-03-31 | $5,777,321 | 17,461 | Shares | Sole | 2026-04-24 | |
| No filing history on record for this holder in this stock. | ||||||